Corporate Responsibility in Australia
In Australia, Novartis Pharmaceuticals provides support for patient groups, research efforts and communities in need. We work to promote the well-being of our associates, and support communities through volunteerism and philanthropic activities and our generics division, Sandoz, helps make affordable, high quality medicines available to more people.
Each year our employees engage in Community Partnership Day and various fundraising events throughout the year focusing on raising awareness of medical conditions and giving back to the community. The Novartis global Malaria Initiative is one of the industry’s largest access-to-medicines programs, providing 500 million treatments without profit to more than 60 malaria endemic countries, including Papua New Guinea and the Solomon Islands.
In this section
- Patient Groups
- Patient groups play a vital role in educating and supporting patients and we remain mindful of their independent perspectives with regard to diseases and their related treatments.
- Grants
- Novartis provides funding opportunities for the purposes of supporting healthcare initiatives from scientific and charitable organisations that directly supports patients
- Our Community
- Novartis is community and we are proud to support Australian charities and groups through our annual Community Partnership Day.
- Financial Transparency
- The new Medicines Australia Code of Conduct will increase transparency about the vital role of healthcare professionals in the development and use of new, innovative medicines.